A gene pathway analysis highlights the role of cellular adhesion molecules in multiple sclerosis susceptibility

Genes and Immunity

Volumn 15, Issue 2, 2014, Pages 126-132

  Damotte, V ^a   Guillot Noel, L ^a   Patsopoulos, N A ^b,c,d   Madireddy, L ^e   El Behi, M ^a   De Jager, P L ^b,c,d   Baranzini, S E ^e   Cournu Rebeix, I ^a,f   Fontaine, B ^a,f  

^a INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cell adhesion molecules; Multiple sclerosis; Pathway analysis; Susceptibility

Indexed keywords

CELL ADHESION MOLECULE; STAT3 PROTEIN; TRANSCRIPTION FACTOR;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; BLOOD BRAIN BARRIER; CELL JUNCTION; GENE CONTROL; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HUMAN; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE;

ANTIGENS, CD; BLOOD-BRAIN BARRIER; CELL ADHESION MOLECULES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTEGRIN ALPHA CHAINS; INTERCELLULAR ADHESION MOLECULE-1; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84895891926     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2013.70     Document Type: Article

References (30)

1. Nylander A, Hafler DA. Multiple sclerosis. J Clin Invest 2012; 122: 1180-1188.
2. Compston A, Coles A. Multiple sclerosis. Lancet 2008; 372: 1502-1517.
3. IMSGC, WTCCC2, Sawcer S, Hellenthal G, Pirinen M, Spencer CC et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214-219.
4. Patsopoulos NA, Esposito F, Reischl J, Lehr S, Bauer D, Heubach J et al. Genomewide meta-Analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol 2011; 70: 897-912.
5. Lill CM, Schjeide BM, Graetz C, Liu T, Damotte V, Akkad DA et al. Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk. J Med Genet 2013; 50: 140-143.
6. Lill CM, Schjeide BM, Graetz C, Ban M, Alcina A, Ortiz MA et al. MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis. Brain 2013; 136(Pt 6): 1778-1782.
7. International Multiple Sclerosis Genetics CBeecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013; 45: 1353-1360.
8. Bush WS, Sawcer SJ, de Jager PL, Oksenberg JR, McCauley JL, Pericak-Vance MA et al. Evidence for polygenic susceptibility to multiple sclerosis-The shape of things to come. Am J Hum Genet 2010; 86: 621-625.
9. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ et al. Finding the missing heritability of complex diseases. Nature 2009; 461: 747-753.
10. Marian AJ. Elements of 'missing heritability'. Curr Opin Cardiol 2012; 27: 197-201.
11. Wang K, Li M, Hakonarson H. Analysing biological pathways in genome-wide association studies. Nat Rev Genet 2010; 11: 843-854.
12. Ramanan VK, Shen L, Moore JH, Saykin AJ. Pathway analysis of genomic data: Concepts, methods, and prospects for future development. Trends Genet 2012; 28: 323-332.
13. Holman DW, Klein RS, Ransohoff RM. The blood-brain barrier, chemokines and multiple sclerosis. Biochim Biophys Acta 2011; 1812: 220-230.
14. Engelhardt B, Wolburg H. Mini-review: Transendothelial migration of leukocytes: Through the front door or around the side of the house? Eur J Immunol 2004; 34: 2955-2963.
15. Engelhardt B, Ransohoff RM. The ins and outs of T-lymphocyte trafficking to the CNS: Anatomical sites and molecular mechanisms. Trends Immunol 2005; 26: 485-495.
16. Engelhardt B. Immune cell entry into the central nervous system: Involvement of adhesion molecules and chemokines. J Neurol Sci 2008; 274: 23-26.
17. Man S, Ubogu EE, Ransohoff RM. Inflammatory cell migration into the central nervous system: A few new twists on an old tale. Brain Pathol 2007; 17: 243-250.
18. Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 1992; 356: 63-66.
19. Polman CH, O'Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2006; 354: 899-910.
20. Cayrol R, Wosik K, Berard JL, Dodelet-Devillers A, Ifergan I, Kebir H et al. Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat Immunol 2008; 9: 137-145.
21. Cournu-Rebeix I, Genin E, Lesca G, Azoulay-Cayla A, Tubridy N, Noe E et al. Intercellular adhesion molecule-1: A protective haplotype against multiple sclerosis. Genes Immun 2003; 4: 518-523.
22. Baranzini SE, Galwey NW, Wang J, Khankhanian P, Lindberg R, Pelletier D et al. Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet 2009; 18: 2078-2090.
23. IMSGC. Network-based multiple sclerosis pathway analysis with GWAS data from 15 000 cases and 30 000 controls. Am J Hum Genet 2013; 92: 854-865.
24. Lee HA, Park I, Byun HJ, Jeoung D, Kim YM, Lee H. Metastasis suppressor KAI1/CD82 attenuates the matrix adhesion of human prostate cancer cells by suppressing fibronectin expression and beta1 integrin activation. Cell Physiol Biochem 2011; 27: 575-586.
25. Mela A, Goldman JE. CD82 blocks cMet activation and overcomes hepatocyte growth factor effects on oligodendrocyte precursor differentiation. J Neurosci 2013; 33: 7952-7960.
26. Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000; 28: 27-30.
27. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 2012; 40(Database issue): D109-D114.
28. Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D. GeneCards: Integrating information about genes, proteins and diseases. Trends Genet 1997; 13: 163.
29. Liu JZ, McRae AF, Nyholt DR, Medland SE, Wray NR, Brown KM et al. A versatile gene-based test for genome-wide association studies. Am J Hum Genet 2010; 87: 139-145.
30. Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C et al. Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2007; 2: 2366-2382.